STAT Plus: With Grail in its sights, Illumina pursues grand vision that could reshape the business of cancer diagnoses
JEFF SPICER/PA WIRE VIA AP
A merger between the two companies, which are currently in talks, could reshape the business of cancer diagnoses.


No hay comentarios:
Publicar un comentario